BACKGROUND: The aim of this work was to study the feasibility, safety, and efficacy of single-incision robotic cholecystectomy using a novel platform from Intuitive Surgical. METHODS: All operations were performed by the same surgeon. Parameters assessed included patient history, indication for surgery, operation time, complication rate, conversion rate, robot-related issues, length of hospital stay, postoperative pain, and time to return to work. All patients were followed for a 2-month period postoperatively. RESULTS: Forty-five patients (22 women, 23 men) underwent single-incision robotic cholecystectomy from March 1 to July 15, 2011. There were no conversions to either conventional laparoscopy or laparotomy, although in three cases a second trocar was used. There were no major complications apart from a single case of postoperative hemorrhage. Average patient age was 47 ± 12 years (range = 27-80 years) and average BMI was 30 kg/m(2) (mean = 28.8 ± 4 kg/m(2), range = 18.4-46.7 kg/m(2)). The primary indication for surgery was gallstones. The mean operation time (skin-to-skin) was 84.5 ± 25.5 min (range = 51-175 min), docking time was 5.8 ± 1.5 min (range = 4-11 min), and console time (net surgical time) was 43 ± 21.9 min (range = 21-121 min). Intraoperative blood loss was negligible. There were no collisions between the robotic arms and no other robot-related problems. Average postoperative length of stay was less than 24 h. The mean Visual Analog Pain Scale Score 6 h after the operation was 2.2 ± 1.51 (range = 0-6) and patients returned to normal activities in 4.48 ± 2.3 days (range = 1-9 days). CONCLUSIONS: Single-Site(®) is a new platform offering a potentially more stable and reliable environment to perform single-port cholecystectomy. Both simple and complicated cholecystectomies can be performed with safety. The technique is possible in patients with a high BMI. The induction of pneumoperitoneum using the new port and the docking process require additional training.
BACKGROUND: The aim of this work was to study the feasibility, safety, and efficacy of single-incision robotic cholecystectomy using a novel platform from Intuitive Surgical. METHODS: All operations were performed by the same surgeon. Parameters assessed included patient history, indication for surgery, operation time, complication rate, conversion rate, robot-related issues, length of hospital stay, postoperative pain, and time to return to work. All patients were followed for a 2-month period postoperatively. RESULTS: Forty-five patients (22 women, 23 men) underwent single-incision robotic cholecystectomy from March 1 to July 15, 2011. There were no conversions to either conventional laparoscopy or laparotomy, although in three cases a second trocar was used. There were no major complications apart from a single case of postoperative hemorrhage. Average patient age was 47 ± 12 years (range = 27-80 years) and average BMI was 30 kg/m(2) (mean = 28.8 ± 4 kg/m(2), range = 18.4-46.7 kg/m(2)). The primary indication for surgery was gallstones. The mean operation time (skin-to-skin) was 84.5 ± 25.5 min (range = 51-175 min), docking time was 5.8 ± 1.5 min (range = 4-11 min), and console time (net surgical time) was 43 ± 21.9 min (range = 21-121 min). Intraoperative blood loss was negligible. There were no collisions between the robotic arms and no other robot-related problems. Average postoperative length of stay was less than 24 h. The mean Visual Analog Pain Scale Score 6 h after the operation was 2.2 ± 1.51 (range = 0-6) and patients returned to normal activities in 4.48 ± 2.3 days (range = 1-9 days). CONCLUSIONS: Single-Site(®) is a new platform offering a potentially more stable and reliable environment to perform single-port cholecystectomy. Both simple and complicated cholecystectomies can be performed with safety. The technique is possible in patients with a high BMI. The induction of pneumoperitoneum using the new port and the docking process require additional training.
Authors: Sigi Joseph; B Todd Moore; G Brent Sorensen; John W Earley; Fengming Tang; Phil Jones; Kimberly M Brown Journal: Surg Endosc Date: 2011-04-13 Impact factor: 4.584
Authors: A Budzyński; M Matłok; M Pędziwiatr; P Budzyński; M Tusiński; A Zub-Pokrowiecka; A Gwóźdź; D Karcz Journal: Adv Med Sci Date: 2011 Impact factor: 3.287
Authors: Arsalla Islam; Antonio O Castellvi; Seifu T Tesfay; Alejandro D Castellvi; Andrew S Wright; Daniel J Scott Journal: Surg Endosc Date: 2011-02-27 Impact factor: 4.584
Authors: Anthony Michael Gonzalez; Jorge Rafael Rabaza; Charan Donkor; Rey Jesús Romero; Radomir Kosanovic; Juan Carlos Verdeja Journal: Surg Endosc Date: 2013-08-13 Impact factor: 4.584
Authors: Lukasz Filip Grochola; Christopher Soll; Adrian Zehnder; Roland Wyss; Pascal Herzog; Stefan Breitenstein Journal: Surg Endosc Date: 2018-09-14 Impact factor: 4.584
Authors: Amir Szold; Roberto Bergamaschi; Ivo Broeders; Jenny Dankelman; Antonello Forgione; Thomas Langø; Andreas Melzer; Yoav Mintz; Salvador Morales-Conde; Michael Rhodes; Richard Satava; Chung-Ngai Tang; Ramon Vilallonga Journal: Surg Endosc Date: 2014-11-08 Impact factor: 4.584
Authors: Shawn Tsuda; Dmitry Oleynikov; Jon Gould; Dan Azagury; Bryan Sandler; Matthew Hutter; Sharona Ross; Eric Haas; Fred Brody; Richard Satava Journal: Surg Endosc Date: 2015-07-24 Impact factor: 4.584
Authors: S Cianci; A Rosati; V Rumolo; S Gueli Alletti; V Gallotta; L C Turco; G Corrado; G Vizzielli; A Fagotti; F Fanfani; G Scambia; S Uccella Journal: World J Surg Date: 2019-10 Impact factor: 3.352
Authors: Anthony Yuen Bun Teoh; Shannon Melissa Chan; Hon Chi Yip; Vivien Wai Yin Wong; Philip Wai Yan Chiu; Enders Kwok Wai Ng Journal: Surg Endosc Date: 2017-08-11 Impact factor: 4.584